Ye Liang

3.7k total citations
76 papers, 1.9k citations indexed

About

Ye Liang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ye Liang has authored 76 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 20 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Ye Liang's work include Cancer, Hypoxia, and Metabolism (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and RNA Interference and Gene Delivery (7 papers). Ye Liang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and RNA Interference and Gene Delivery (7 papers). Ye Liang collaborates with scholars based in China, United States and Germany. Ye Liang's co-authors include Liping Wang, Zhijuan Liang, Yuanbin Chen, Haitao Niu, Dan Li, Wenhua Xu, Xuecheng Yang, Guofeng Ma, Baoqin Han and Wanshun Liu and has published in prestigious journals such as Biomaterials, Biochemical and Biophysical Research Communications and Journal of Colloid and Interface Science.

In The Last Decade

Ye Liang

73 papers receiving 1.9k citations

Peers

Countries citing papers authored by Ye Liang

Since Specialization

Citations

This map shows the geographic impact of Ye Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Liang more than expected).

Fields of papers citing papers by Ye Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Liang. The network helps show where Ye Liang may publish in the future.

Co-authorship network of co-authors of Ye Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Liang. A scholar is included among the top collaborators of Ye Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Liang. Ye Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design of a Cost-Effective Ultrasound Force Sensor and Force Control System for Robotic Extra-Body Ultrasound Imaging 2025 ·Sensors ·(unknown), (unknown), (unknown), (unknown), (unknown), Lukas Lindenroth, Zhouyang Xu, Weizhao Wang, (unknown), Steve Morris, Ye Liang, Xiaolong Fu, Kawal Rhode, R. James Housden	4
2	Functional cobalt-doped hydrogel scaffold enhances concurrent vascularization and neurogenesis 2025 ·Journal of Nanobiotechnology ·Junqing Liu, Jun Kang, Ting Zou, (unknown), (unknown), (unknown), Ye Liang, (unknown), Yi Zhao, Xi Wei, (unknown)	0
3	Microtubule interacting and trafficking domain containing 1 deficiency leads to poor survival via tissue factor-mediated coagulation in bladder cancer 2024 ·Journal of Thrombosis and Haemostasis ·Yuanbin Chen, Wei Jiao, Yonghua Wang, Zhijuan Liang, Liping Wang, Dan Li, Ye Liang, Haitao Niu	0
4	Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer 2024 ·Cancer Immunology Research ·Guofeng Ma, (unknown), Zhiqiang Li, (unknown), Liping Wang, (unknown), (unknown), Zhijuan Liang, Dan Li, (unknown), (unknown), (unknown), Ye Liang, Haitao Niu	3
5	Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation 2024 ·Cancer Letters ·(unknown), Ye Liang, Fei Xie, Zhao Zhang, Pengfei Zhang, (unknown), Zhilei Zhang, Zhijuan Liang, Dan Li, Liping Wang, Yuanbin Chen, (unknown), Haitao Niu, Yonghua Wang	26
6	Integration of STING activation and COX-2 inhibition via steric-hindrance effect tuned nanoreactors for cancer chemoimmunotherapy 2024 ·Biomaterials ·Pengfei Zhang, (unknown), (unknown), (unknown), (unknown), Ye Liang, Yanfeng Shi, (unknown), (unknown), (unknown), Yuanhong Xu	17
7	Cannabinoid receptor 2 plays a key role in renal fibrosis through inhibiting lipid metabolism in renal tubular cells 2024 ·Metabolism ·Shan Zhou, (unknown), Ye Liang, (unknown), (unknown), Jiemei Li, Qiyan Chen, Jinhua Miao, (unknown), Zhiru Li, Weiwei Shen, Xiaolong Li, Qinyu Wu, Xiaoxu Wang, Fan Fan Hou, Youhua Liu, Yaozhong Kong, Lili Zhou	13
8	Comparison of the efficacy and safety of total laparoscopic hysterectomy without and with uterine manipulator combined with pelvic lymphadenectomy for early cervical cancer 2023 ·Journal of obstetrics and gynaecology research ·Weihong Zeng, Ye Liang, (unknown), (unknown), Li‐Shan Huang, Danfeng He, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
9	Synthesis and application of zeolitic imidazolate frameworks-based nucleic acid delivery system in tumor diagnosis and therapy: a review 2023 ·Biomedical Materials ·Liping Wang, Zhijuan Liang, Dan Li, Yuanbin Chen, Guofeng Ma, Ye Liang	5
10	Establishment of a novel pork kidney lavage method and detection of heavy metals and antibiotics 2022 ·Food Science and Technology ·Zhijuan Liang, (unknown), Dan Li, Ye Liang, Liping Wang, (unknown), Haitao Niu	2
11	Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer 2021 ·BMC Cancer ·Zhao Zhang, Yongbo Yu, Pengfei Zhang, Guofeng Ma, Mingxin Zhang, Ye Liang, Wei Jiao, Haitao Niu	18
12	Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network 2021 ·Cancers ·Xinyan Wu, Li Wang, Nicole A Pearson, Santosh Renuse, Ran Cheng, Ye Liang, Dong‐Gi Mun, Anil K. Madugundu, (unknown), Parkash S. Gill, Akhilesh Pandey	6
13	NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes 2021 ·Stem Cell Research & Therapy ·Xinyuan Zhang, Ye Liang, Hao Xu, Qin Zhou, Bin Tan, Qin Yi, Yan Liang, Min Xie, (unknown), Jie Tian, Jing Zhu	17
14	C3, C3AR1, HLA-DRA, and HLA-E as potential prognostic biomarkers for renal clear cell carcinoma 2020 ·Translational Andrology and Urology ·(unknown), Wei Jiao, Xuecheng Yang, Ye Liang, Zhiqiang Li, Haitao Niu	11
15	Research progress of medicinal secondary metabolites and gene cloning of Dendrobium officinale. 2019 ·Medicinal plant ·Ye Liang, (unknown), (unknown), (unknown), (unknown)	1
16	Tissue-engineered membrane based on chitosan for repair of mechanically damaged corneal epithelium 2014 ·Journal of Materials Science Materials in Medicine ·Ye Liang, Wenhua Xu, Baoqin Han, Na Li, Weiwei Zhao, Wanshun Liu	17
17	A vertebrate case study of the quality of assemblies derived from next-generation sequences 2011 ·Genome biology ·Ye Liang, LaDeana W. Hillier, Patrick Minx, (unknown), Devin P. Locke, John Martin, Lei Chen, Makedonka Mitreva, Jason Miller, (unknown), David J. Dooling, Elaine R. Mardis, Richard K. Wilson, George M. Weinstock, Wesley C. Warren	29
18	Fabrication and characters of a corneal endothelial cells scaffold based on chitosan 2010 ·Journal of Materials Science Materials in Medicine ·Ye Liang, Wanshun Liu, Baoqin Han, Chaozhong Yang, Qun Ma, Weiwei Zhao, (unknown), Hui Li	73
19	An in situ formed biodegradable hydrogel for reconstruction of the corneal endothelium 2010 ·Colloids and Surfaces B Biointerfaces ·Ye Liang, Wanshun Liu, Baoqin Han, Chaozhong Yang, Qun Ma, Fulai Song, Qing-Qing Bi	85
20	STRAIN E26 OF AGROBACTERIUM RADIOBACTER EFFICIENTLY INHIBITS CROWN GALL FORMATION ON GRAPEVINES 1990 ·科学通报(英文版) ·Ye Liang	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact